DHHS/NIH: Conference for Early Stage HIV/AIDS Vaccine Researchers

Deadline: 6 September 2016

The National Institutes of Health (NIH), an agency of the Department of Health and Human Services (DHHS) is seeking applications from eligible organisations for a program entitled “Conference for Early Stage HIV/AIDS Vaccine Researchers” with an aim to conduct intensive workshop/conference/meeting(s) that address the needs of early stage HIV/AIDS vaccine researchers as they translate preclinical research from nonhuman primates (NHPs) to human clinical trials.

The objectives of the meeting is to provide early stage HIV/AIDS vaccine researchers with guidance on conducting preclinical research to inform HIV vaccine strategies for clinical trials and developing skills related to networking, work-life balance, grantsmanship, and goal/milestone-oriented projects.

Focus Areas

Critical aspects of human vaccine development, including statistical considerations, host genetics and others;
Methods to translate the results of NHP challenge studies to clinical trials in humans;
Methods to develop milestone-driven projects.
Key aspects of career development, including starting a laboratory, securing funding, work-life balance, goal-oriented career tracking, and others.
Networking early stage vaccine scholars with senior/established investigators.

Funding Information

Application budgets cannot exceed $100,000 direct costs per meeting per year.
The project period must be three years, with a maximum of one meeting per year.

Eligibility Criteria

Higher Education Institutions
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- U.S. Territory or Possession
Foreign Institutions
- Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
- Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
- Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.